Posted by Michael Wonder on 29 Oct 2021
PBS arrangements for tocilizumab shortage – 1 November 2021
29 October 2021 - In response to the shortages of multiple presentations of tocilizumab (Actemra) products, the PBAC has recommended temporary changes to the PBS listings for biological medicines in order to facilitate timely access to appropriate alternative therapies.
These changes will avoid inaccurate categorisation and recording of the switch from tocilizumab to an alternative, as a treatment failure with Services Australia.
